Neogen Corporation reports developments tied to its food safety and animal safety businesses, including diagnostic tests, environmental monitoring products, veterinary products and related manufacturing operations. Company updates commonly cover foodborne pathogen detection, Listeria testing, AOAC method certification, Petrifilm manufacturing activity, and product quality or recall matters involving animal health products.
Neogen news also includes quarterly operating results, segment performance in Food Safety and Animal Safety, business transformation updates, leadership and compliance appointments, and governance matters. Its recurring disclosures connect scientific validation, manufacturing execution, customer markets and regulatory interactions across food safety, livestock, and pet health and wellness applications.
Neogen (NASDAQ: NEOG) announced its participation in the 44th Annual William Blair Growth Stock Conference on June 4, 2024, in Chicago, Illinois. John Adent, the company's President and CEO, will present at 8:00 a.m. Central Time. The presentation materials will be available on Neogen's Investor Relations website on the same day. Investors and interested parties can access the webcast and materials through the Events & Presentations section at neogen.com/investor-relations/events-presentations.
Neogen (NASDAQ: NEOG) will participate in the Bank of America 2024 Health Care Conference in Las Vegas, Nevada, on May 15, 2024.
Neogen (NEOG) will participate in the 2024 RBC Capital Markets Global Healthcare Conference in New York. John Adent, the CEO, will present on May 14, 2024, at 4:05 PM Eastern Time. Investors can access the webcast and presentation materials on Neogen's Investor Relations website.
Neogen® (NASDAQ: NEOG) is celebrating 40 years of Petrifilm, a groundbreaking solution that has revolutionized microbiological testing in the food safety industry. With over 2.85 billion plates used worldwide and 105+ global validations, Petrifilm has significantly increased productivity, reduced testing time, and saved space in laboratories. Neogen remains committed to providing high-quality, innovative solutions to maintain its position as a global leader in food safety.
Neogen® introduced the Neogen Molecular Detection Assay 2 – Salmonella Enteritidis/Salmonella Typhimurium (MDA2SEST) to add to their pathogen testing platform, helping enhance food safety in the poultry industry. The new assay offers improved accuracy, reduced time to results, and a streamlined workflow. It detects specific Salmonella serotypes, aiding in reducing foodborne illness. The product has been approved by the AOAC® Research Institute, and it is part of the award-winning Neogen Molecular Detection System platform.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.